Literature DB >> 8059110

Efforts to recruit the economically disadvantaged to national clinical trials.

M S McCabe1, C G Varricchio, R M Padberg.   

Abstract

Clinical trials are vital for the development of state-of-the-art cancer prevention and treatment. A goal for trial recruitment should be to have a representative sample of the total population by gender, race, culture, ethnicity, and socioeconomic status as appropriate. Increased sensitivity to the unique barriers and access to care issues required to achieve a representative sample are necessary. Knowledge and understanding of recruitment problems and strategies to resolve them are developing; however, much more is needed before we can fully address and resolve all of the relevant issues. Nurses have a key role in identification, education, and recruitment of special populations including the SED to clinical trials.

Entities:  

Mesh:

Year:  1994        PMID: 8059110     DOI: 10.1016/s0749-2081(05)80066-x

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  11 in total

1.  The Tuskegee Legacy Project: history, preliminary scientific findings, and unanticipated societal benefits.

Authors:  Ralph V Katz; S Stephen Kegeles; B Lee Green; Nancy R Kressin; Sherman A James; Cristina Claudio
Journal:  Dent Clin North Am       Date:  2003-01

2.  Barriers to and strategies for recruiting Korean Americans for community-partnered health promotion research.

Authors:  Hae-Ra Han; Jeonghee Kang; Kim B Kim; Jai P Ryu; Miyong T Kim
Journal:  J Immigr Minor Health       Date:  2007-04

3.  An ethno-medical perspective on research participation: a qualitative pilot study.

Authors:  José L Calderón; Richard S Baker; Horacio Fabrega; José G Conde; Ron D Hays; Erik Fleming; Keith Norris
Journal:  MedGenMed       Date:  2006-04-25

4.  Why do those who request smoking treatment fail to attend the first appointment?

Authors:  Peter Gariti; Sarah Levin; Thomas Whittingham; Daniela Barou; Kyle M Kampman; Kevin Lynch; Chanita Hughes Halbert; Arthur Alterman
Journal:  J Subst Abuse Treat       Date:  2007-10-10

5.  Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort.

Authors:  V E Stone; M Y Mauch; K Steger; S F Janas; D E Craven
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

6.  Patient income level and cancer clinical trial participation.

Authors:  Joseph M Unger; Dawn L Hershman; Kathy S Albain; Carol M Moinpour; Judith A Petersen; Kenda Burg; John J Crowley
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

7.  Development and Validation of the Biomedical Research Trust Scale (BRTS) in English and Spanish.

Authors:  Sharon H Baik; Mariana Arevalo; Clement Gwede; Cathy D Meade; Paul B Jacobsen; Gwendolyn P Quinn; Kristen J Wells
Journal:  J Empir Res Hum Res Ethics       Date:  2016-09-21       Impact factor: 1.742

8.  Oncologists' knowledge, attitudes and practices related to cancer treatment clinical trials.

Authors:  Momi Kaanoi; Kathryn L Braun; Carolyn C Gotay; Lehua Abrigo
Journal:  Hawaii Med J       Date:  2002-05

9.  Pitfalls in health communication: healthcare policy, institution, structure, and process.

Authors:  José L Calderón; Robert A Beltrán
Journal:  MedGenMed       Date:  2004-01-07

10.  An institutional strategy to increase minority recruitment to therapeutic trials.

Authors:  Victoria V Anwuri; Lannis E Hall; Katherine Mathews; Brian C Springer; Jennifer R Tappenden; Dione M Farria; Sherrill Jackson; Melody S Goodman; Timothy J Eberlein; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2013-07-12       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.